MAM
KITE

Martingale Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Martingale Asset Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-9,303
Closed -$537K – 939
2015
Q1 		$537K Buy
+9,303
New +$623K 0.01% 691

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Martingale Asset Management's KITE Position: Q2 2015 in Review

Martingale Asset Management sold out of Kite Pharma, Inc. (KITE) in Q2 2015, closing a stake of 9,303 shares — an estimated $537K sold.

Martingale Asset Management first reported a position in KITE in Q1 2015 and held it in 1 quarter. The position peaked at $537K in Q1 2015. 155 funds tracked by Wall St. Rank hold KITE as of Q2 2015.

  • Martingale Asset Management reported no remaining Kite Pharma, Inc. position as of Q2 2015 after selling out during the quarter.
  • Martingale Asset Management sold 9,303 Kite Pharma, Inc. shares in Q2 2015, an estimated $537K.
  • Martingale Asset Management first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 1 quarter.
  • Martingale Asset Management's Kite Pharma, Inc. position peaked at $537K in Q1 2015.
  • 155 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2015.

Based on Martingale Asset Management's 13F filing for Q2 2015, filed 12 Aug 2015.